It has been suggested that inhibition of occludin may act on TJs directly or indirectly to bind with factors that regulate cell proliferation, differentiation and cell cycle, receiving and imparting PKC and Rho protein etc. molecular signaling, regulating tumor cell survival [34]. The gene discussed is PRRT2; the disease is neoplasm.